BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2547331)

  • 1. Clinical use of gynaecologic tumour markers.
    Halila H; Alfthan H; Stenman UH
    Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour markers in gynaecologic oncology.
    Onsrud M
    Scand J Clin Lab Invest Suppl; 1991; 206():60-70. PubMed ID: 1719611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
    Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
    Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
    Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 72.4, SCC, 90 K].
    Garzetti GC; Di Lauro RM; Ciavattini A; Pallotta MR; Marchegiani F; Valensise H; Tranquilli AL; Arduini D; Romanini C
    Ann Ostet Ginecol Med Perinat; 1991; 112(5):320-3. PubMed ID: 1817444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical relevance of tumor markers].
    Lamerz R
    Wien Klin Wochenschr; 1989 Jul; 101(14):464-72. PubMed ID: 2672606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in gynecological and breast cancer].
    Jobo T; Sato R; Kuramoto H
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of urinary beta-core fragment of hCG as a tumor marker of cervical cancer].
    Kinugasa M; Nishimura R; Hasegawa K; Okamura M; Kimura A; Ohtsu F; Takeuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):188-94. PubMed ID: 1545171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
    Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
    Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of polyamine determination in monitoring malignant gynaecological tumours.
    Szarka G; Pulay T; Csömör S; Tran-Phuong-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):365-72. PubMed ID: 3239336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
    Ulsperger E; Karrer K
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):33-43. PubMed ID: 2545372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
    Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T; Ota J; Sumida S; Rii M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.